Topiramate in pregnancy: Preliminary experience from the UK epilepsy and pregnancy register

Neurology

Volumn 71, Issue 4, 2008, Pages 272-276

  Hunt, S ^a   Russell, A ^b   Smithson, W H ^c   Parsons, L ^d   Robertson, I ^e   Waddell, R ^a   Irwin, B ^a   Morrison, P J ^f   Morrow, J ^a   Craig, J ^a  

^a ROYAL GROUP OF HOSPITALS   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^c Surgery   (United Kingdom)

^d St Albans City Hospital   (United Kingdom)

^e LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE;

ABDOMINAL CYST; ADULT; ANTICONVULSANT THERAPY; ANUS ATRESIA; ARTICLE; BIRTH WEIGHT; CAVERNOUS HEMANGIOMA; CLEFT LIP; CLEFT PALATE; CLICKY HIP; CONGENITAL HEART MALFORMATION; CONGENITAL HIP DISLOCATION; CONGENITAL MALFORMATION; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GESTATIONAL AGE; GLANDULAR HYPOSPADIAS; HERNIA; HUMAN; HYDROCELE; HYDRONEPHROSIS; HYPOSPADIAS; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MYOCLONUS EPILEPSY; NEWBORN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PATIENT REFERRAL; PLAGIOCEPHALY; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PYLORUS STENOSIS; REGISTER; RISK FACTOR; SACRAL DIMPLE; TOE WEBBING; TONIC CLONIC SEIZURE; TRACHEOESOPHAGEAL FISTULA; UNITED KINGDOM; VESICOURETERAL REFLUX; CHEMICALLY INDUCED DISORDER; CONFIDENCE INTERVAL; DRUG COMBINATION; INCIDENCE; SAMPLE SIZE;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICONVULSANTS; CLEFT PALATE; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; GESTATIONAL AGE; GREAT BRITAIN; HUMANS; HYPOSPADIAS; INCIDENCE; INFANT, NEWBORN; MALE; PREGNANCY; PROSPECTIVE STUDIES; REGISTRIES; SAMPLE SIZE;

EID: 50549083309     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000318293.28278.33     Document Type: Article

References (14)

1. EUROCAT Annual Report to WHO 2004-5. Available at: http://www.eurocat. ulster.ac.uk/pdf/EUROCAT-Annual-Report-2005-for-WHO.pdf. Accessed January 2008.
2. Olafsson E, Hallgrimsson JT, Hauser WA, Ludvigsson P, Gudmundsson G. Pregnancies of women with epilepsy: a population-based study in Iceland. Epilepsia 1998;39: 887-892.
3. Holmes LB, Harvey EA, Coull BA, et al. The teratogenic-ity of anticonvulsant drugs. N Engl J Med 2001;344: 1132-1138.
4. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999; 46:739-746.
5. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-198.
6. Cunnington M, Tennis P, et al. Lamotrigine and the risk of malformations in pregnancy. Neurology 2005;64:955-960.
7. Hunt S, Craig J, Russell A, et al. Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2006;67:1876-1879.
8. Meischenguiser R, D'Giano CH, Ferraro SM. Oxcarbaz-epine in pregnancy: clinical experience in Argentina. Epilepsy Behav 2004;5:163-167.
9. FDA product characteristics (2003). Available at: http:// www.fda.gov/medwatch/SAFETY/2003/03APR-PI/To-pamax-PI.pdf. Accessed March 2007.
10. Kwarta RF, Hulihan JF, Schmider J, Nye JS. Pregnancy outcomes in topiramate-treated women. Epilepsia 2006; 47, suppl 4:119-204. Abstract.
11. de Wals P, Mastroiacovo P, Weatherall JAC, et al., eds. EUROCAT Guide for the Registration of Congenital Anomalies. Brussels: European Union, 1984.
12. Vajda FJ, O'Brien TJ, Hitchcock, et al. A critical relationship between sodium valproate dose and human teratoge-nicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci 2004;11:854-858.
13. Harper PS. Practical Genetic Counseling, 6th ed. Arnold; 2004.
14. Abdullah NA, Pearce MS, Parker L, Wilkinson JR, Jaffray B, McNally RJ. Birth prevalence of cryptorchidism and hypospadias in northern England, 1993-2000. Arch Dis Child 2007;92:576-579.